Sugemalimab is the world’s first anti-PD-L1 monoclonal antibody approved for use in combination with fluorouracil and platinum-based chemotherapy for unresectable locally advanced, recurrent or metastatic esophageal squamous cell carcinoma. This marks the 13th NDA approval obtained by CStone and sugemalimab’s fourth indication approved in China, following stage III and IV non-small cell lung cancer and relapsed or refractory extranodal NK/T-cell lymphoma. The GESMTONE-304 study met its pre-specified dual primary endpoints. Treatment of sugemalimab in combination with fluorouracil plus cisplatin demonstrated a statistically significant and clinically meaningful improvement in the progression-free survival and overall survival of patients with unresectable locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma in the first-line setting.

SUZHOU, China, Dec. 8, 2023 /PRNewswire/ — CStone Pharmaceuticals ("CStone", HKEX: 2616), a leading biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology therapies and precision medicines, today announced that the National Medical Products Administration (NMPA) of China has approved the supplemental biologics license application (sBLA) for sugemalimab (Cejemly®) in combination with fluorouracil and platinum-based chemotherapy as first-line treatment of unresectable locally advanced, recurrent, or metastatic esophageal squamous cell carcinoma (ESCC). Sugemalimab becomes the world’s first anti-PD-L1 monoclonal antibody approved for the first-line ESCC indication.

Dr. Jason Yang, CEO of CStone, said, "We are excited about the approval of sugemalimab for the fourth indication in first-line ESCC, which further demonstrates its clinical significance and potential. In additional to the approved indications such as non-small cell lung cancer (NSCLC), NK/T-cell lymphoma, and ESCC, sugemalimab is currently under review for its sBLA for the first-line treatment of gastric cancer. We are keeping active and productive communication with the NMPA to secure early approval in China and will also work with the FDA and EMA to explore registration pathways in the U.S, Europe and other territories. We look forward to benefiting more patients with ESCC around the world with sugemalimab."

Professor Li Jin, Principal Investigator of the GEMSTONE-304 study and Director of the Department of Oncology, East Hospital, Tongji University, said, "Esophageal cancer is a prevalent malignancy in China, with ESCC being the most common in terms of pathological type. About 70% of patients with esophageal cancer have progressed to locally advanced or advanced stages at the time of initial diagnosis. In addition, 50%-60% of patients with resectable esophageal cancer relapse or develop distant metastases after radical surgery. The GEMSTONE-304 study demonstrated that sugemalimab in combination with chemotherapy significantly improved progression-free survival (PFS) and overall survival (OS) compared to first-line chemotherapy for ESCC, with a manageable safety profile. We believe, with this approval, sugemalimab will provide a new first-line treatment option to patients with advanced ESCC."

This sBLA of sugemalimab was approved based on the data from the GEMSTONE-304 study. It is a randomized, double-blind, multi-center, placebo-controlled phase 3 registrational clinical trial designed to evaluate the efficacy and safety of sugemalimab in combination with 5-fluorouracil plus cisplatin as first-line treatment in patients with unresectable locally advanced, recurrent, or metastatic ESCC. The primary endpoints are Blinded Independent Central Review (BICR)-assessed PFS and OS, and secondary endpoints include investigator-assessed PFS, BICR and investigator-assessed objective response rate (ORR) and duration of response (DoR).

The GEMSTONE-304 study results were presented at the 2023 ESMO World Congress on Gastrointestinal Cancer (ESMO GI 2023) in an oral presentation. The study met its pre-specified dual primary endpoints. The results showed that sugemalimab in combination with chemotherapy demonstrated a statistically significant and clinically meaningful improvement in BICR-assessed PFS and OS compared with placebo in combination with chemotherapy. Sugemalimab in combination with chemotherapy showed good tolerability and safety, with no new safety signal observed. The safety profile was consistent with previous findings across studies in other diseases with sugemalimab. The BICR-assessed median PFS in the sugemalimab treatment group is 6.2 months compared with 5.4 months in the placebo group, with a hazard ratio (HR) of 0.67 (95% CI, 0.54-0.82), and a p-value of 0.0002. The median OS in the sugemalimab treatment group is 15.3 months compared with 11.5 months in the placebo group, with an HR of 0.70 (95% CI, 0.55-0.90), and a p-value of 0.0076. Subgroup analysis demonstrated that consistent clinical benefits were observed across almost all predefined subgroups regardless of PD-L1 expression level. The BICR- assessed ORR is 60.1% vs 45.2%, with a difference of 14.9%. The DoR is 6.0 months vs 4.5 months.

About esophageal cancer

Esophageal cancer is one of the most common cancers globally. According to the GLOBOCAN 2020 data, there were more than 600,000 new cases of esophageal cancer in the world in 2020 (ESCC accounts for about 85%), and 544,000 deaths, with the incidence and mortality ranking 9th and 6th, respectively, among cancers globally. The incidence of esophageal cancer in China accounts for more than half of the world, about 90% of which are ESCC, and most of the patients with ESCC have been diagnosed in the advanced stage and missed the opportunities of curative treatments.

About sugemalimab

The anti-PD-L1 monoclonal antibody sugemalimab was discovered by CStone using the OmniRat® transgenic animal platform, which allows creation of fully human antibodies in one step. Sugemalimab is a fully human, full-length anti-PD-L1 immunoglobulin G4 (IgG4) monoclonal antibody, which may reduce the risk of immunogenicity and toxicity for patients, a unique advantage over similar drugs.

The NMPA of China has approved sugemalimab for four indications:

In combination with chemotherapy for first-line treatment of patients with metastatic squamous and non-squamous NSCLC. For the treatment of patients with unresectable Stage III NSCLC whose disease has not progressed following concurrent or sequential platinum-based chemoradiotherapy. For the treatment of patients with relapsed or refractory extranodal NK/T-cell lymphoma. In combination with fluorouracil and platinum-based chemotherapy for first-line treatment of patients with unresectable locally advanced, recurrent or metastatic ESCC.

The sBLA for sugemalimab in combination with chemotherapy for first-line treatment of locally advanced or metastatic gastric or gastroesophageal junction (G/GEJ) adenocarcinoma has been accepted by the NMPA of China and is currently under review.

The European Medicines Agency (EMA) and the Medicines and Healthcare products Regulatory Agency (MHRA) in the United Kingdom have both accepted the marketing authorization applications (MAAs) for sugemalimab in combination with chemotherapy as a first-line treatment for metastatic NSCLC, and the two MAAs are currently under review.

CStone formed a strategic collaboration agreement with Pfizer that includes the development and commercialization of sugemalimab in mainland China, and a framework to bring additional Oncology medicines to the Greater China market.

About CStone

CStone (HKEX: 2616) is a biopharmaceutical company focused on research, development, and commercialization of innovative immuno-oncology and precision medicines to address the unmet medical needs of cancer patients in China and worldwide. Established in 2015, CStone has assembled a management team with extensive experience in innovative drug development, clinical research, and commercialization. The company has built an oncology-focused pipeline of 14 drug candidates with a strategic emphasis on immuno-oncology combination therapies. Currently, CStone has received 13 NDA approvals for its four drugs. Multiple late-stage drug candidates are now under pivotal clinical trials or registration. CStone’s vision is to bring innovative oncology therapies to cancer patients worldwide.

For more information about CStone, please visit www.cstonepharma.com.

Forward-looking statements

The forward-looking statements made in this article only relate to events or information as of the date when the statements are made in this article. Except as required by law, we undertake no obligation to update or publicly revise any forward-looking statements, whether as a result of new information, future events or otherwise, after the date on which the statements are made or to reflect the occurrence of unanticipated events. You should read this article completely and with the understanding that our actual future results or performance may be materially different from what we expect. All statements in this article are made on the date of publication of this article and may change due to future developments.

Source : CStone Announces NMPA Approval of Sugemalimab as First-line Treatment for Esophageal Squamous Cell Carcinoma

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

BEIJING, Dec. 8, 2023 /PRNewswire/ — iQIYI, an innovative market-leading online entertainment service in China, attended the 2023 Asia TV Forum (ATF) held in Singapore from December 5 to 8. WANG Xiaohui, Chief Content Officer of iQIYI, joined a fireside chat onsite and emphasized the platform’s unwavering commitment to providing premium Chinese and Asian content worldwide. iQIYI strives to enhance content creation, bolster competitiveness through cutting-edge technology, and foster strong partnerships to promote global reach and ensure sustained growth.

The continuous creation of premium content remains a cornerstone for Chinese streaming platforms to establish a global presence. According to Wang, iQIYI leverages its advantageous resources to produce exceptional original content, embracing innovative themed theater models to create exquisite masterpieces that resonate with ordinary individuals.

Simultaneously, iQIYI is dedicated to fortifying its content studio by fostering a diverse talent pool, supporting the creation of content across various genres to meet the diverse viewing needs of users from all walks of life.

Wang said, "Diversifying content was our response to the influx of diverse internet users in China’s streaming landscape. We expanded beyond popular IPs of ancient fantasy and embraced a range of genres like sci-fi, mystery, romance, and more, catering to the varied tastes of different age groups, social backgrounds, and aesthetic preferences. We want to tell the stories of the ordinary people."

At the forum, iQIYI unveiled an impressive lineup for the next two years, including over 280 new Chinese language dramas, films, and variety shows, as well as over 35 original productions and licensed series from Southeast Asia. According to Wang, iQIYI has successfully extended its content reach to over 200 territories worldwide, distributing approximately 7,800 episodes of dramas, variety shows, documentaries, and around 400 films over the years.

iQIYI has also embraced cutting-edge technologies, incorporating artificial intelligence throughout the content production pipeline. From project planning and assessment to on-the-ground development, production, and promotional activities, iQIYI leverages AI to enhance efficiency and elevate the quality of content. This strategic integration simplifies the creative process and enriches the depth of artistic expression. With the sustained and stable output of high-quality content, iQIYI solidifies its core competitiveness, fostering increased user engagement and brand loyalty.

Launching its international version of website www.iq.com and international app in 2019, iQIYI has striven to become the home for beloved Asian content for audiences worldwide and is committed to contributing to the Asian entertainment industry through in-house production, content distribution, and local partnerships. iQIYI International is accessible via almost any internet-connected device across the world, with UI and subtitles of 12 languages.

ATF is Asia’s leading entertainment content market and conference, bringing together industry professionals from around the world to trade, collaborate, and explore business opportunities in the Asian television and entertainment industry.

CONTACT: iQIYI Press, press@qiyi.com

Source : iQIYI's Chief Content Officer at Asia TV Forum: Driving Premium Chinese Content to Global Prominence

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Mandopop saw a 45% growth in streams in the past year; Jay Chou, JJ Lin and Eason Chan top the list of most-streamed Mandopop artists

HONG KONG, Dec. 8, 2023 /PRNewswire/ — Spotify, the world’s most popular audio streaming service, has launched its annual Wrapped campaign, unveiling how more than 574 million people around the globe listened this year.

The Dark Plum Sauce (烏梅子醬) by Ronghao Li is the Global Top Mandopop Songs of the Year, 2023

As part of the celebrations of the top artists and songs that formed the world’s soundtrack to 2023, Spotify is also putting the spotlight on Mandopop: a genre that has scaled the globe and proven that music, from anywhere in the world, can transcend time, and language and cultural boundaries.

Here are the Global Top Mandopop Artists and Songs of 2023 Spotify Wrapped

Jay Chou, the undisputed King of Mandopop, dominates as the Global Top Mandopop Artist of 2023. Once again proving his longstanding influence in the music industry, three of his songs charted on Global Top Mandopop Songs –  晴天 (#3) a well loved hit in the past two decades, 擱淺 coming hot at #4, and 說好不哭 (#8), his more recent work.

Well-loved through the decades, JJ Lin (#2), Eason Chan (#3) and Jolin Tsai (#10) also maintain their stronghold on the list of Global Top Mandopop Artists as they continue to captivate listeners. Alongside these Mandopop icons are rising stars Eric Chou (#4) and 告五人 (#7), who’ve brought fresh sounds to fans of the genre.

The Top Global Mandopop Song of the Year goes to Ronghao Li‘s The Dark Plum Sauce (烏梅子醬). In a testament to the genre’s significance in key cultural moments, five of the top 10 list of most-streamed Mandopop songs are featured in some of the hottest movies and TV shows. This includes WeiBird‘s Red Scarf (如果可以) (#2), Shi Shi‘s Remembered (眼淚記得你) (#5), 831‘s Miss You 3000 (想見你想見你想見你) (#6) and Eric Chou‘s How Have You Been? (你，好不好？) (#9) and Graduation (最後一堂課) (#10).

Spotify’s reach has enabled fans and listeners from all over the world to connect with Mandopop and markets like Brazil, Mexico and Germany are amongst the latest markets seeing increased consumption.

"It’s incredible to see Mandopop consumption growing globally as Spotify continues to connect music cultures with audiences from all over the world, showcasing a slate of extraordinary talents – both seasoned and emerging, driving music discovery. 2023 Spotify Wrapped is all about celebrating the real, the realer and the realest listening moments that defined our year, and as we look ahead, we’re excited to continue in our efforts to foster the further discovery of the genre while deepening connections between artists and listeners," says Kossy Ng, Spotify Head of Music, Asia

Head to this playlist on Spotify to listen to our editor’s picks for the best Mandopop tracks of 2023, including the songs in this year’s top 20 list of Global Mandopop Top Songs: Best of 最 Hit 華語榜 2023.

The full 2023 Wrapped Global Top Mandopop lists can be found below.  Media Assets are available for download HERE.

2023 Spotify Wrapped Global Top Mandopop Lists

Global Top Mandopop Artists of the Year, 2023

Jay Chou JJ Lin Eason Chan Eric Chou G.E.M. Mayday 告五人 Ronghao Li Zhang Zhehan Jolin Tsai

Global Top Mandopop Female Artists of the Year, 2023

G.E.M. Jolin Tsai Tanya Chua Stefanie Sun A-Mei Chang Fish Leong A-Lin Cyndi Wang Hebe Tien Karen Mok

Global Top Mandopop Male Artists of the Year, 2023

Jay Chou JJ Lin Eason Chan Eric Chou Ronghao Li Zhang Zhehan 高爾宣 OSN Joker Xue WeiBird David Tao

Global Top Mandopop Groups of the Year, 2023

Mayday  告五人 Bestards Sodagreen (oaeen) No Party For Cao Dong EggPlantEgg  S.H.E F.I.R. 831 Power Station

Global Top Mandopop Songs of the Year, 2023

The Dark Plum Sauce (烏梅子醬) by Ronghao Li Red Scarf (如果可以) by WeiBird Sunny Day (晴天) by Jay Chou Step Aside (擱淺) by Jay Chou Remembered (眼淚記得你) by Shi Shi Miss You 3000 (想見你想見你想見你) by 831 Lonely Warrior (孤勇者) by Eason Chan Won’t Cry (說好不哭) by Jay Chou How Have You Been? (你，好不好？) by Eric Chou Graduation (最後一堂課) by Eric Chou

###

ABOUT SPOTIFY

Spotify transformed music listening forever when we launched in 2008. Our mission is to unlock the potential of human creativity by giving a million creative artists the opportunity to live off their art and billions of fans the opportunity to enjoy and be inspired by these creators. Everything we do is driven by our love for music.

Discover, manage, and share over 100 million tracks, including 5 million podcast titles, and 350,000 audiobooks, for free, or upgrade to Spotify Premium to access exclusive features including improved sound quality and an on-demand, offline, and ad-free listening experience.

Today, we are the world’s most popular audio streaming subscription service with a community of more than 574 million users, including 226 million Spotify Premium subscribers, across more than 180 markets. We are also the largest driver of revenue to the music business today.

For more information, images, or to contact the press team, please head over to our press page at https://newsroom.spotify.com/.

MEDIA CONTACT

Spotify Southeast Asia
[email protected]

Source : 2023 Spotify Wrapped: How the world listened to Mandopop this year

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

SHANGHAI, Dec. 8, 2023 /PRNewswire/ — Aon plc (NYSE: AON), a leading global professional services firm, today announced it has released the China Best ESG Employers Award list for 2023, with 23 organizations awarded ‘Best environmental, social and governance (ESG) Employer’ and another eight earning individual awards for outstanding performance in their specific fields.

The award[1] recognizes businesses accelerating ESG practices while striving to enhance their employee value proposition beyond employee experience and engagement.

The launch of the inaugural China Best ESG Employers Award last year was well received by the business community, as ESG is increasingly seen as a key to success. Enterprises are pursuing high-quality and sustainable growth through driving organizational optimization and agile operation models, as well as focusing on technological innovation with a view to expanding globally.

In assessing the China Best ESG Employers Award recipients, Aon implemented a rigorous review of the 225 participating companies over a six-month period through a questionnaire, employee survey and leadership interviews across four areas: responsibility, maturity, resilience and agility.

Responsibility

How a company integrates and upholds its ESG commitments and how it influences its respective industry, clients and employees is an essential component in assessing the China Best ESG Employer Awardees. This year’s survey revealed more than half of the participants noted clear requirements concerning ESG or sustainability initiatives, such as using recyclable materials or meeting certain labor force criteria. Among the Best ESG Employer awardees, 82 percent revealed that employees are important partners of ESG practices. It is clear that embedding ESG into corporate culture is essential to help employees understand and implement their purpose.

In conducting this year’s survey, Aon also employed the use of an advanced neurological survey tool to more accurately capture the reliability of participants’ responses. Interestingly, the tool found there was a disparity between some participants’ responses versus what they actually believe to be true. For example, in one question company employees were asked whether ‘sustainable development is one of the key strategies of my company’ with 85 percent answering that it was. However, in tracking how long it took the respondent to answer the question it was determined only 73 percent actually strongly believed this. The gap widens further on questions regarding the consideration of the environment in business decisions, as well as managing ESG effectively. It is clear that there is still a way to go to help employees recognize and support their company’s ESG practices and sustainable growth strategy.

Maturity

Many companies have recognized the importance of ESG since last year’s awards and have already initiated discussions or created plans around ESG issues. Aon found that multinational corporations tend to develop their ESG purpose at their headquarters and optimize it to better fit local markets. For example, in China the inclusion and diversity focus might be more on age diversity rather than gender.

For companies in China, ESG concerns may instead be focused on establishing China’s ESG evaluation system, which is a challenge for all companies while also considering the need for high-quality and balanced development. However, Aon’s survey results showed that the daily management of ESG targets is not widely recognized by employees. For example, only 63 percent of employees agreed that ‘management is responsible for implementing ESG targets’ while 56 percent agreed that the ‘leadership team has necessary skills to achieve ESG targets.’ The ratio is slightly higher for Best ESG Award winners, reaching 71 percent and 65 percent respectively, demonstrating that companies still have a long way to go in terms of their maturity around ESG.

Resilience and Agility

Both resilience and agility are a focus for organizations today: resilience can help companies to face risks while agility can help seize opportunities. In this year’s survey, more than 60 percent of participants claimed to adjust their organizational structure once a year, and 35 percent adjust it every six months. These changes are driven by the pursuit of faster responses, better products and smoother communications.

When evaluating resilience and agility, Aon focuses not only on the organization’s performance, but also the health and wellbeing of employees, such as engagement and dedication to their work, understanding of strategy, ownership of performance and willingness to engage in long-term development. This year’s awardees demonstrated a commitment to employee wellbeing, offering practical benefits for housing and retirement, incentive measures to unite and inspire employees, and the willingness to structure and reshape their workforce by reskilling or retraining staff.

Peter Zhang, head of Aon’s Talent Solutions for Asia Pacific and chairman of the judge committee of China Best ESG Employers Award, said: "Many companies focus on the short-term and consider ESG a ‘nice to have’. However, more and more organizations are realizing that the way they address ESG issues will be key to their long-term resilience and success, because at the core of ESG is high-quality and sustainable growth."

2023 China Best ESG Employers Award List

(in alphabet order)

2023 China Best ESG Employers

ANTA Group

Autoliv China

CanSinoBIO

CATL

CICC

CPIC

Fufeng Group

GienTech

Hisense

HSBC China

IHG Hotels & Resorts

KINGDOM HOLDINGS LIMITED

KWEICHOW MOUTAI GROUP

Lonza China

L’Oréal China

Luckin Coffee

McDonald’s China

MetLife

MSD China

Novartis China

OCBC Bank Limited

Starbucks China

Yum China

2023 China Best ESG Employers – Individual Awards

Beyondsoft – Diversity Award

Fresenius Medical Care China – Social Committement Award

Hasten Biopharma – ESG Seed Award

Ipsen China – Evolving Award

Jotun Cosco – Innovation Award

Orange Connex – Agility Award

Royal FrieslandCampina China – Social Responsibility Award

Watsons China – Health & Wellbeing Award

About Aon

Aon plc (NYSE: AON) exists to shape decisions for the better — to protect and enrich the lives of people around the world. Our colleagues provide our clients in over 120 countries and sovereignties with advice and solutions that give them the clarity and confidence to make better decisions to protect and grow their business.  

Follow Aon on LinkedIn, Twitter, Facebook and Instagram. Stay up-to-date by visiting the Aon Newsroom and sign up for News Alerts here.

[1] Best employer from ESG perspective, which more focuses on "S" and "G" and not "E".

Source : Aon Releases the China Best ESG Employers Award List for 2023

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

~ King’s University College and UEL sign MoU to unite for a Five-Year Partnership ~

HO CHI MINH CITY, Vietnam, Dec. 8, 2023 /PRNewswire/ — King’s University College (King’s) in London, Canada, a leader in global education, has solidified a significant partnership with the University of Economics and Law (UEL) at Viet Nam National University in Ho Chi Minh City, Vietnam. The signing of a new MoU follows productive meetings and collaboration between the institutions in Vietnam earlier this year.

The five-year agreement marks the beginning of a collaborative venture that includes student exchange programs for study abroad initiatives. King’s and UEL are exploring the possibility of a 2+2 pathway or dual degree options, providing students with enhanced educational opportunities. Moreover, the partnership encourages the exchange of faculty and staff for workshops, seminars, lectures, joint research projects, and potential co-authored publications.

Reflecting on the partnership, Dr. David Malloy, President of King’s University College, expressed enthusiasm and said, "Upon meeting in-person with UEL faculty and administration in Ho Chi Minh City, we quickly realized our shared synergies of cultural, ethical, and academic standards." He went on to add, "I was honored to have spent time with Professor Le Vu Nam, Vice President of UEL, in Vietnam, and I am so thrilled that we were able to finalize our partnership upon my return to Canada. I know our students, faculty, and staff would find UEL to be a perfect place for a global exchange, and we can’t wait to welcome UEL students, faculty, and staff to King’s."

This partnership exemplifies a commitment to fostering global perspectives, academic excellence, and cultural understanding for the benefit of students and faculty from both institutions. The collaboration is poised to create meaningful opportunities for cross-cultural learning and research collaboration.

Associate Professor Le Vu Nam, Vice President of the University of Economics and Law of UEL extended his sincerest wishes for success and prosperity for both universities in their work together to make the new cooperation successful.

"I strongly believe that our cooperation is an important step that contributes to improving the quality of education and training for both of us. As an educator, I am deeply concerned about my responsibility of nurturing our new generation of citizens, in particular how to make the students of the University of Economics and Law have the opportunity to approach new knowledge, expand their horizons, and integrate with the world education, so that they can develop their inherent qualities of intelligence, dynamism, and diligence. Therefore, our cooperation program on student exchange, as well as the upcoming 2+2 Degree program is absolutely a great opportunity for them. Besides, I also hope that the joint teaching and scientific research activities, as well as the exchange of faculty and staff between UEL and King’s will bring positive results for our educational activities, leading to the cultural and social development in Vietnam and Canada."

This MoU marks another milestone of growth in Vietnam for King’s following two new partnerships signed in October 2023 and signifies Vietnam’s growth in the international higher education market. Both the institutes believe that these partnerships will benefit the exchange of students, faculty, staff, and researchers involved as an opportunity to develop new perspectives, ideas, and knowledge.

Photo – https://mma.prnewswire.com/media/2295645/UEL_Campus.jpg

Source : Canada based King's University College and University of Economics and Law (UEL) Forge Transformative Educational Alliance

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

Dubai, UAE, Dec. 8, 2023 /PRNewswire/ — Optasia, a leading Fintech services provider, proudly announces the deployment of its Airtime Advance solutions in Ivory Coast through Mobile Telephone Network Cote D’Ivoire (MTN), a major telecommunications provider in the region.

The Airtime Advance solution powered by Optasia is offered in Ivory Coast through MTN, Optasia’s long-standing partner, under the commercial name of "XtraTime". Optasia will enable the approximately 17 million eligible customers to benefit from the airtime advance services supported by the cutting-edge scoring and delivery technology that the Optasia AI-led platform offers.

"Both teams have worked hard on delivering this deployment with functionality and capabilities which will improve the customer experience," stated Mark Muller, CEO of Optasia. "This is only a part of the overall plan of similar deployments with MTN, a valued partner in the region, and we are happy to enable an AI-led service that will benefit the millions of MTN subscribers in Ivory Coast."

Patrick Attoungbre, CEO of Fintech MTN CI, also shared his perspective on the partnership, saying, "This collaboration with Optasia represents a significant step forward in our commitment to providing innovative financial solutions to our customers. The ‘XtraTime’ solution will empower millions of MTN subscribers in Ivory Coast, enhancing their digital experience and financial flexibility."

The deployment of Optasia’s solutions in Ivory Coast follow the projected Optasia roadmap for 2023 and beyond. Optasia’s capabilities to provide powerful, flexible solutions to its partners, thanks to its proprietary AI-led platform, guarantees that more people worldwide can benefit from them in a hassle-free, consistent manner, through Optasia’s partners.

About Optasia

Optasia, previously Channel VAS, is an advanced AI-led platform which enables instant access to financial solutions for millions of underbanked individuals and SMEs across 35 countries, mainly in Emerging Markets. Optasia’s B2B2X (business-to-business-to-customers and SMEs) model creates value for its partners, such as mobile network operators, mobile money operators, banks and payment gateways, in the form of additional revenue, enhanced customer experience and improved retention without the need for additional operating or capital expense. The company’s AI-led data engine and proprietary algorithms analyze alternative data from mobile and other environments to provide relevant instant credit decisions to its partners. These capabilities enable micro-lending, airtime and data advances via mobile wallets, SIM cards, and other digital environments.

Source : OPTASIA DEPLOYS AIRTIME ADVANCE SOLUTIONS IN IVORY COAST THROUGH MTN

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network

AUBURN HILLS, Mich., Dec. 8, 2023 /PRNewswire/ — Nexteer Automotive has been awarded on Newsweek’s list of America’s Most Responsible Companies 2024. This prestigious award is presented by Newsweek and Statista Inc., the world-leading statistics portal and industry ranking provider. This marks the fourth time in five years that Nexteer has earned this recognition for the Company’s environmental, social and corporate governance (ESG) performance.

America’s Most Responsible Companies ranking focuses on a holistic view of corporate responsibility that considers all three pillars of ESG. The analysis is based on two metrics:

1.  KPI research: The KPI research formed the first part of the detailed analysis. Over 30 KPIs have been researched for the top 2,000 public companies by revenue with headquarters in the USA.

2.  Public Survey: The survey was the second part of the detailed analysis to evaluate the companies’ corporate social responsibility (CSR) reputation. 17,000 US residents were surveyed. Respondents were asked to select companies familiar to them and then to evaluate the company’s CSR performance in general and in the three subdimensions: social, environmental and governance.

In the final step, an overall score was calculated for each company that had been analyzed. The final list recognizes the top 600 most responsible companies in the United States, spanning 14 industries.

"Nexteer is proud to once again be recognized for our ESG commitments in Newsweek’s List of America’s Most Responsible Companies for the fourth time in five years," said Robin Milavec, President, Chief Technology Officer (CTO), Chief Strategy Officer (CSO), Executive Board Director and Chair of the Sustainability Steering Committee, Nexteer Automotive. "Sustainability is a key part in achieving our vision to be the global leading motion control technology company accelerating mobility to be safe, green and exciting. Across the globe, our One Nexteer team collaborates and innovates to create solutions that make tomorrow better than today."

To learn more about Nexteer’s overall ESG/sustainability efforts, please visit the Company’s sustainability webpage. Nexteer’s sustainability framework operates through five key focus areas: Business Ethics; Supply Chain; Environmental, Health and Safety; Community; and Value Creation.

To view the full list of America’s Most Responsible Companies 2024, please visit the Newsweek website.

About Nexteer

Nexteer Automotive (HK 1316) is a global leading motion control technology company accelerating mobility to be safe, green and exciting. Our innovative product and technology portfolio includes electric and hydraulic power steering systems, steer-by-wire systems, steering columns and intermediate shafts, driveline systems and software solutions. The company solves motion control challenges across all megatrends – including electrification, software/connectivity, ADAS/automated driving and shared mobility – for more than 60 customers around the world including BMW, Ford, GM, RNM, Stellantis, Toyota and VW, as well as automakers in India and China including BYD, Chery, Great Wall, Geely, Xpeng and others. www.nexteer.com

About Statista 

Statista publishes hundreds of worldwide industry rankings and company listings with high profile media partners. This research and analysis service is based on the success of statista.com, the leading data and business intelligence portal that provides statistics, business relevant data, and various market and consumer studies and surveys.

Link to Nexteer Media Center

Source : Nexteer Recognized on Newsweek's America's Most Responsible Companies 2024 List

>

This content was prepared by our news partner, Cision PR Newswire. The opinions and the content published on this page are the author’s own and do not necessarily reflect the views of Siam News Network